חזרה לתוצאות החיפוש

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Type 2 Diabetes

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Helios Clinical Research - Phoenix, Phoenix, Arizona, United States

    Study coordinator · 480-372-5996
    Contact: Principal Investigator (David Francyk)

  • Wolverine Clinical Trials, Santa Ana, California, United States

    Study coordinator · 714-617-2426
    Contact: Principal Investigator (Behnam Khaleghi)

  • Renstar Medical Research, Ocala, Florida, United States

    Study coordinator · 352-629-5800
    Contact: Principal Investigator (David Oliver)

  • Oviedo Medical Research, Oviedo, Florida, United States

    Study coordinator · 407-977-2705
    Contact: Principal Investigator (Bradley Block)

  • Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville, Georgia, United States

    Study coordinator · 770-696-4541
    Contact: Principal Investigator (Nadia Cameron, MD)

  • Physicians Research Associates, Lawrenceville, Georgia, United States

    Study coordinator · 678-252-2375
    Contact: Principal Investigator (Ola Odugbesan)

  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City, Georgia, United States

    Study coordinator · 470-317-3604
    Contact: Principal Investigator (Dwight Blake)

  • North Georgia Clinical Research, Woodstock, Georgia, United States

    Study coordinator · 678-494-5735
    Contact: Principal Investigator (Bram Wieskopf)

  • Elite Clinical Trials, Rexburg, Idaho, United States

    Study coordinator · 208-356-8977
    Contact: Principal Investigator (Brian Beesley)

  • Investigators Research Group, Brownsburg, Indiana, United States

    Study coordinator · 317-852-8280
    Contact: Principal Investigator (Kenneth Maynard)

  • Clinical Research of Philadelphia, Pennington, New Jersey, United States

    Study coordinator · 215-676-6696
    Contact: Principal Investigator (Taher Modarressi)

  • NYC Research INC, Long Island City, New York, United States

    Study coordinator · 516-574-9232
    Contact: Principal Investigator (Anastasios Manessis)

  • Richmond University Medical Center, Staten Island, New York, United States

    Study coordinator · 718-818-2430
    Contact: Principal Investigator (Philip Otterbeck)

  • Southgate Medical Group, West Seneca, New York, United States

    Study coordinator · 716-712-1004
    Contact: Principal Investigator (Brian Snyder)

  • Lucas Research, Inc., Morehead City, North Carolina, United States

    Study coordinator · 252-222-5700
    Contact: Principal Investigator (Kathryn Lucas)

  • Shelby Clinical Research, Shelby, North Carolina, United States

    Study coordinator · 980-552-9230
    Contact: Principal Investigator (Christian Martin)

  • Providence Health Partners-Center for Clinical Research, Dayton, Ohio, United States

    Study coordinator · 937-297-8994
    Contact: Principal Investigator (Paul Opsahl)

  • Alliance for Multispecialty Research, LLC, Norman, Oklahoma, United States

    Study coordinator · 405-701-8999
    Contact: Principal Investigator (Lisa Connery)

  • Frontier Clinical Research, LLC, Scottdale, Pennsylvania, United States

    Study coordinator · 724-220-5281
    Contact: Principal Investigator (Tiffany Pluto)

  • Juno Research, Houston, Texas, United States

    Study coordinator · 713-779-5494
    Contact: Principal Investigator (Damaris Vega)

  • Southern Endocrinology Associates, Mesquite, Texas, United States

    Study coordinator · 214-693-0904
    Contact: Principal Investigator (Sumana Gangi)

  • Texas Diabetes & Endocrinology, P.A., Round Rock, Texas, United States

    Study coordinator · 512-334-3505
    Contact: Principal Investigator (Srujana Yada)

  • Consano Clinical Research, LLC, Shavano Park, Texas, United States

    Study coordinator · 210-545-4900
    Contact: Principal Investigator (Michelle Welch)

  • Texas Valley Clinical Research, Weslaco, Texas, United States

    Study coordinator · 956-431-8090
    Contact: Principal Investigator (Eduardo Luna)

  • Eastside Research Associates, Redmond, Washington, United States

    Study coordinator · 425-869-6828
    Contact: Principal Investigator (Chad Crystal)

  • Centricity Research Brampton Endocrinology, Brampton, Canada

    Study coordinator · 905 595 0560
    Contact: Principal Investigator (Harpreet Bajaj)

  • Ecogene-21, Chicoutimi, Canada

    Study coordinator · 418-545-1252
    Contact: Principal Investigator (Daniel Gaudet)

  • Winterberry Research Inc., Hamilton, Canada

    Study coordinator · 365-366-6267
    Contact: Principal Investigator (Steven Zizzo)

  • Viacar Recherche Clinique, Longueuil, Canada

    Contact: Principal Investigator (Genevieve Mathieu)

  • G A Research Associates, Moncton, Canada

    Study coordinator · 506-852-9865
    Contact: Principal Investigator (Jocelyn Cormier)

  • Bluewater Clinical Research Group Inc., Sarnia, Canada

    Study coordinator · 1 (519) 344-6612
    Contact: Principal Investigator (John O'Mahony)

  • Maple Leaf Research, Toronto, Canada

    Study coordinator · 4164657936
    Contact: Principal Investigator (Graham Smith)

  • Diabetes Heart Research Centre, Toronto, Canada

    Study coordinator · 4169245871
    Contact: Principal Investigator (Luis Noronha)

  • Fadia El Boreky Medicine, Waterloo, Canada

    Study coordinator · 519-569-7592
    Contact: Principal Investigator (Fadia El Boreky)

  • InnoDiab Forschung Gmbh, Essen, Germany

    Study coordinator · 49 201 89942100
    Contact: Principal Investigator (Helga Zeller)

  • Velocity Clinical Research, Leipzig, Leipzig, Germany

    Study coordinator · +4934126825556
    Contact: Principal Investigator (Thomas Mueller)

  • Gemeinschaftspraxis Dr. Taeschner/Dr. Bonigut, Leipzig, Germany

  • Institut für Diabetesforschung GmbH Münster, Münster, Germany

    Study coordinator · 0049 251 935 2321
    Contact: Principal Investigator (Ludger Rose)

  • RED-Institut GmbH, Oldenburg, Germany

    Study coordinator · 0049436150630128
    Contact: Principal Investigator (Thomas Schaum)

  • Legeartis - Poradnie Specjalistyczne, Bialystok, Poland

    Study coordinator · 48 507 18 11 18
    Contact: Principal Investigator (Anna Modzelewska)

  • Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Poland

    Study coordinator · 48603790004
    Contact: Principal Investigator (Monika Lukaszewicz)

  • Medyczne Centrum Diabetologiczno Endokrynologiczno Metaboliczne DIAB-ENDO-MET, Krakow, Poland

    Study coordinator · 48126237122
    Contact: Principal Investigator (Joanna Mirocka)

  • Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz, Poland

    Study coordinator · 607536360
    Contact: Principal Investigator (Malgorzata Jozefowska)

  • Ekamed, Lublin, Poland

    Study coordinator · 48603787884
    Contact: Principal Investigator (Ewa Skokowska)

  • Private Practice - Dr. Robert Witek, Tarnów, Poland

    Study coordinator · 48721000040
    Contact: Principal Investigator (Robert Witek)

  • NBR Polska, Warsaw, Poland

    Study coordinator · 48514876203
    Contact: Principal Investigator (Katarzyna Klodawska)

  • Szpital Czerniakowski, Warsaw, Poland

    Study coordinator · 4847722052
    Contact: Principal Investigator (Olga Turowska)

  • 4 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ, Wroclaw, Poland

    Study coordinator · 71 7210 873
    Contact: Principal Investigator (Mateusz Tabin)

  • Centro de Endocrinologia Alcantara Gonzalez, Bayamón, Puerto Rico

    Study coordinator · 7877870933
    Contact: Principal Investigator (Altagracia Alcantara-Gonzalez)

  • Mgcendo Llc, San Juan, Puerto Rico

    Study coordinator · 7874842757
    Contact: Principal Investigator (Martha Gomez-Cuellar)

  • FutureMeds - Birmingham, Birmingham, United Kingdom

    Study coordinator · 0121 592 2050
    Contact: Principal Investigator (Tehmina Ahmed)

  • Layton Medical Centre, Blackpool, United Kingdom

    Study coordinator · 441253951943
    Contact: Principal Investigator (Rebecca Clark)

  • Southmead Hospital, Bristol, United Kingdom

    Study coordinator · 0117 4148125
    Contact: Principal Investigator (Georgina Russell)

  • FutureMeds - Liverpool, Bromborough, United Kingdom

    Study coordinator · 01513150090
    Contact: Principal Investigator (Connor McGladdery)

  • Futuremeds-Newcastle, Newcastle, United Kingdom

    Study coordinator · 07775506109
    Contact: Principal Investigator (Martin Johnson)

  • Newquay Health Centre, Newquay, United Kingdom

    Study coordinator · 01637857903
    Contact: Principal Investigator (Rutesh Patel)

  • George Eliot Hospital, Nuneaton, United Kingdom

    Study coordinator · 02476153592
    Contact: Principal Investigator (Ponnusamy Saravanan)

  • The Adam Practice, Poole, United Kingdom

    Study coordinator · 01202 339050
    Contact: Principal Investigator (Patrick Moore)

  • Clifton Medical Centre, Rotherham, United Kingdom

    Study coordinator · 01709363950
    Contact: Principal Investigator (Matthew Capehorn)

  • Rame Group Practice, Torpoint, United Kingdom

    Study coordinator · (0044) 1752 817900
    Contact: Principal Investigator (Susan Keast)
מובילי המחקר

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)